Although the correlation analysis between serum sclerostin and clinical parameters such as ABI showed a relatively weak to moderate correlation, this may reflect the multifactorial nature of PAD, in which no single biomarker fully explains disease variance. The gene discussed is SOST; the disease is peripheral arterial disease.